Literature DB >> 22416253

A case study of human papillomavirus-associated bladder carcinoma developing after urethral condyloma acuminatum.

Shohei Kawaguchi1, Kazuyoshi Shigehara, Toshiyuki Sasagawa, Masato Kuribayashi, Akira Junicho, Toru Hasegawa, Yuji Maeda, Mikio Namiki.   

Abstract

We report a 35-year-old man with bladder carcinoma developing 2 months after urethral condyloma acuminatum, with an 8-year history of persistent human papilloma virus-58 infection in the urinary tract. DNA was extracted from paraffin-embedded tissue specimens. Human papilloma virus-6 and -58 were detected in the condyloma, whereas human papilloma virus-58 was detected in the carcinoma. In situ hybridization analysis also demonstrated high-risk human papilloma virus-DNA signals in the condyloma and carcinoma tissues. Immunohistochemistry showed that p16-INK4a and mcm-7, surrogate markers of oncogenic human papilloma virus E7 protein, were weakly expressed in the condyloma tissue but were strongly expressed in the carcinoma tissues, suggesting that human papilloma virus-58 was present in the episomal state in the condyloma, whereas human papilloma virus-58 DNA was integrated into the host cells and its infection may have a role in the development of bladder carcinoma. Human papilloma virus-58 was continuously detected in the urethral brushing samples 8 years after treatment for urethral condyloma, and human papilloma virus-58 infection was still persistent in the urethra.

Entities:  

Mesh:

Year:  2012        PMID: 22416253     DOI: 10.1093/jjco/hys024

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  2 in total

1.  Innumerable Condyloma Acuminatum Tumors of the Bladder.

Authors:  Alexandra J Murray; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Urol Case Rep       Date:  2017-04-01

2.  A case of condyloma acuminate after about 30 years of urinary obstructive symptoms.

Authors:  Negar Behtash; Seyed Mohammad Kazam Aghamir; Seyed Saeed Tamehri Zadeh; Fateme Guitynavard
Journal:  Urol Case Rep       Date:  2020-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.